Little blue pill sparks a whole new flame? (Wow!)

It seems like ages ago when that little blue pill was all the rage.

Well, as it turns out, that discrete drug may be able to spark a whole NEW flame…

This time, for your brain.

An unexpected boost

I’m talking about Viagara (sildenafil) and its impact on Alzheimer’s disease (AD).

Researchers used artificial intelligence (AI) to integrate patient data from two databases—MarketScane Medicare Supplemental (2012-2017) and Clinformatics (2007-2020).

Then, they looked at potential neuroprotective health outcomes of sildenafil against four other commonly used drugs.

Ultimately, compared to those controls, researchers found that sildenafil reduced the incidence of AD by an impressive 30-54 percent!

And this isn’t even the first study to suggest a protective effect against neurodegenerative diseases, like AD…

In fact, other studies have linked phosphodiesterase type 5 (PDE 5) inhibitors, the class of drug that sildenafil falls under, to decreased levels of neurotoxic proteins in brain cells.

Not to mention, researchers found a dose-dependent response…

The more sildenafil, the less tau formation (a key protein that’s associated with the formation of AD).

I guess that begs the question: Why isn’t this being used clinically yet? Especially considering these findings could prove to be a boon for Big Pharma.

The data looks promising… and safe

I’m pretty excited about the possibility of turning to an older drug to help combat one of the most debilitating diseases of our time.

After all, we have absolutely nothing in the pharmaceutical world that even comes close to being effective against AD.

And while it’s important to call for more clinical trials, I have to say… this drug has been on the market for decades. And it’s quite cheap for consumers. So, what’s the hold up?

Plus, there’s another PDE5 inhibitor, tadalafil—which is prescribed for daily use to help against excessive urination—that already has safety data. Why not turn there?

Of course, the biggest question on my mind is: Does this work for both men and women?

In the meantime, I’m going to routinely discuss this viable option with my patients. And I’ll likely start prescribing it when it makes sense to do so.

I encourage you to ask your treating physician about the brain-boosting potential of PDE5 inhibitors, like sildenafil, too.

P.S. To learn about an all-natural protocol to protect and restore memory, strengthen focus, and fight dementia, I encourage you to check out my Alzheimer’s Prevention and Treatment Plan. Click here now!

Source:

“New Data Support Viagra for Alzheimer’s Prevention.” Medscape, 03/12/2024. (medscape.com/viewarticle/new-data-support-viagra-alzheimers-prevention-2024a10004md)